Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT03715933
Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Phase 1 · Spain, France, United Kingdom, Italy, Netherlands, United States · 37 sites
Registry update: 8 Sept 2026
NCT03589729
Recruiting
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
Phase 2 · United States · 1 site
Registry update: 22 May 2026
NCT04025541
Recruiting
Analysis of Circulating Tumor Markers in Blood
Not applicable · France · 2 sites
Registry update: 2 Apr 2025
NCT03465592
Recruiting
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
Phase 1/2 · United States · 4 sites
Registry update: 5 Feb 2026
NCT03442465
Recruiting
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Not applicable · United States · 5 sites
Registry update: 17 Apr 2026
NCT03422198
Recruiting
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
Phase 3 · United States · 5 sites
Registry update: 12 Dec 2025
NCT03458520
Recruiting
Pediatric PET/MR Image Registry
Not applicable · United States · 1 site
Registry update: 9 Feb 2026
NCT02838602
Recruiting
Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
Not applicable · France · 21 sites
Registry update: 2 Sept 2021
NCT03300830
Recruiting
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Not applicable · United States · 1 site
Registry update: 16 Oct 2026
NCT03093909
Recruiting
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Phase 1 · United States · 1 site
Registry update: 15 Jul 2026
NCT03261544
Recruiting
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
Not applicable · United States · 1 site
Registry update: 15 Jul 2026
NCT03099681
Recruiting
An Observational Study on Epithelioid Sarcoma
Not applicable · Italy · 11 sites
Registry update: 18 Nov 2025
NCT03016819
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Phase 3 · China, Spain, United Kingdom, Italy, United States · 24 sites
Registry update: 25 Feb 2026
NCT03449264
Recruiting
Development of Clinical and Biological Database
Not applicable · France · 1 site
Registry update: 12 Feb 2025
NCT03141021
Recruiting
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Not applicable · Canada, United Kingdom, India, Japan, United States · 13 sites
Registry update: 9 Mar 2026
NCT03138161
Recruiting
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Phase 1/2 · United States · 1 site
Registry update: 24 Feb 2025
NCT03050268
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Not applicable · United States · 1 site
Registry update: 17 Jun 2026
NCT04308330
Recruiting
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Phase 1 · United States · 1 site
Registry update: 15 Apr 2026
NCT03093116
Recruiting
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Phase 1/2 · Australia, Belgium, Canada, China, Germany, Denmark, Spain, France, United Kingdom, Hong Kong, Hungary, Italy, Japan, South Korea, Netherlands, Poland, Singapore, Taiwan, United States · 143 sites
Registry update: 27 May 2026
NCT06836492
Recruiting
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Phase 3 · China · 1 site
Registry update: 20 Feb 2025

Ordered by registry start date. Freshness and sponsorship never change the order.